IL202523A0 - Buspirone for the treatment of mausea and vomiting - Google Patents

Buspirone for the treatment of mausea and vomiting

Info

Publication number
IL202523A0
IL202523A0 IL202523A IL20252309A IL202523A0 IL 202523 A0 IL202523 A0 IL 202523A0 IL 202523 A IL202523 A IL 202523A IL 20252309 A IL20252309 A IL 20252309A IL 202523 A0 IL202523 A0 IL 202523A0
Authority
IL
Israel
Prior art keywords
mausea
buspirone
vomiting
treatment
Prior art date
Application number
IL202523A
Original Assignee
Acacia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acacia Pharma Ltd filed Critical Acacia Pharma Ltd
Publication of IL202523A0 publication Critical patent/IL202523A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
IL202523A 2007-06-07 2009-12-06 Buspirone for the treatment of mausea and vomiting IL202523A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0710981.2A GB0710981D0 (en) 2007-06-07 2007-06-07 New Therapeutic use
PCT/GB2008/001803 WO2008149062A1 (en) 2007-06-07 2008-05-27 Buspirone for the treatment of nausea and vomiting

Publications (1)

Publication Number Publication Date
IL202523A0 true IL202523A0 (en) 2010-06-30

Family

ID=38318932

Family Applications (1)

Application Number Title Priority Date Filing Date
IL202523A IL202523A0 (en) 2007-06-07 2009-12-06 Buspirone for the treatment of mausea and vomiting

Country Status (4)

Country Link
CN (1) CN101678024A (en)
GB (1) GB0710981D0 (en)
IL (1) IL202523A0 (en)
WO (1) WO2008149062A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2388005A1 (en) * 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
MA39147B1 (en) 2013-12-17 2019-12-31 Esteve Labor Dr Combinations of serotonin-norepinephrine reuptake inhibitors (snri) and sigma receptor ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943428A (en) * 1987-07-10 1990-07-24 Wright State University Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones

Also Published As

Publication number Publication date
GB0710981D0 (en) 2007-07-18
CN101678024A (en) 2010-03-24
WO2008149062A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
HK1208237A1 (en) Methods for the treatment of gout
EP2361089A4 (en) Compositions and methods for the treatment of altered -synuclein function
EP2249854A4 (en) Improved treatment and prophylaxis
EP2114900A4 (en) Thiopyrimidine-based compounds and uses thereof
EP2331155A4 (en) Biocomposites and methods of making the same
GB0602357D0 (en) Authentication of cheques and the like
GB0718972D0 (en) Compounds and methods of making the compounds
HK1168843A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
AP2011005637A0 (en) Carbazole compounds and therapeutic uses of the compounds.
IL201018A0 (en) Novel asparaginases and uses thereof
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
ZA201001261B (en) 1-amino-alklcyclohexane derivatives for the treatmrnt and prevention of hearing loss
GB0718446D0 (en) Compositions and methods for the treatment of infection
EP1996218A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
ZA200903401B (en) The uses of the carboxy-amido-triazole compounds and salts thereof
IL205137A0 (en) 5-cyanothienopyridines for the treatment of tumours
IL202523A0 (en) Buspirone for the treatment of mausea and vomiting
EP2174885A4 (en) Water-disintegrable sheet and pouch made of the same for excreta-holding wear
EP2150270A4 (en) Methods and compositions for the treatment of cancer
PL381862A1 (en) Application of pyridine compounds and the manner of treatment
ZA201005282B (en) Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
EP2156827A4 (en) Poultice and process for producing the poultice
EP2285398A4 (en) Methods and compositions for the treatment of obesity
GB0723100D0 (en) Treatment of HFnEF
GB0714500D0 (en) composition and treatment